Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05817383 · ClinicalTrials.gov registry record · NA
Berries, Bugs, and the Blues
A NA study, sponsored by Hebrew SeniorLife.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05817383: Completed NA study, sponsored by Hebrew SeniorLife.
NCT05817383 is a NA study that has completed, run by Hebrew SeniorLife. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05817383, a NA study, has completed, sponsored by Hebrew SeniorLife.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study aims to investigate the impact of daily freeze-dried blueberry powder consumption on the gut microbiota, fecal short chain fatty acids, and depressive symptom severity in 40older, sedentary adults with depressive symptoms.
Primary Outcome
Severity of depressive symptoms will be measured before and after the intervention with the Center for Epidemiological Studies Depression Scale-Revised (CESD-R). Scores range from 0 to 60 points, with higher scores indicating more sever depressive symptoms.
Interventions
- OTHER Freeze-dried Blueberry Powder
- OTHER Placebo Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-04-05 |
| Est. Completion | 2024-07-16 |
| Phase | NA |
What the finished NCT05817383 record still lists
NCT05817383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Freeze-dried Blueberry Powder is the first listed.
NCT05817383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05817383 about?
NCT05817383 is a clinical study titled "Berries, Bugs, and the Blues". This study aims to investigate the impact of daily freeze-dried blueberry powder consumption on the gut microbiota, fecal short chain fatty acids, and depressive symptom severity in 40older, sedentary adults with depressive symptoms.
What is the current status of trial NCT05817383?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-04-05. Estimated completion is 2024-07-16.
What interventions are being tested in trial NCT05817383?
The interventions under investigation include: Freeze-dried Blueberry Powder (OTHER), Placebo Powder (OTHER).
Who is sponsoring clinical trial NCT05817383?
This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05817383's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI